|
SELO expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.078400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.178600E-01 |
| Normal-vs-Stage2 |
9.662400E-01 |
| Normal-vs-Stage3 |
3.386800E-01 |
| Normal-vs-Stage4 |
2.981000E-01 |
| Stage1-vs-Stage2 |
9.131800E-01 |
| Stage1-vs-Stage3 |
3.876600E-01 |
| Stage1-vs-Stage4 |
2.811400E-01 |
| Stage2-vs-Stage3 |
5.026800E-01 |
| Stage2-vs-Stage4 |
4.019400E-01 |
| Stage3-vs-Stage4 |
6.954600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.376400E-01 |
| Normal-vs-AfricanAmerican |
5.603800E-01 |
| Normal-vs-Asian |
4.222200E-01 |
| Caucasian-vs-AfricanAmerican |
6.796200E-01 |
| Caucasian-vs-Asian |
2.712800E-01 |
| AfricanAmerican-vs-Asian |
2.739200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.413000E-01 |
| Normal-vs-Female |
2.725000E-01 |
| Male-vs-Female |
1.034190E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.396400E-01 |
| Normal-vs-Age(41-60Yrs) |
7.249000E-01 |
| Normal-vs-Age(61-80Yrs) |
4.670400E-01 |
| Normal-vs-Age(81-100Yrs) |
8.773000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.331000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.104200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.076800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.121400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.177200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.131200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.55540000004828E-06 |
| Classical-VS-Follicular |
5.377600E-01 |
| Classical-VS-Other |
9.669000E-01 |
| Classical-VS-Normal |
8.342200E-01 |
| Tall-VS-Follicular |
1.480170E-03 |
| Tall-VS-Other |
1.509580E-01 |
| Tall-VS-Normal |
3.61690000000303E-05 |
| Follicular-VS-Other |
8.800200E-01 |
| Follicular-VS-Normal |
5.002800E-01 |
| Other-VS-Normal |
8.867000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.893200E-01 |
| Normal-vs-N1 |
6.904800E-01 |
| N0-vs-N1 |
7.141800E-01 |
|
|
